Suggestions
Elena Medo
Chairman, CEO Medolac Laboratories, A Public Benefit Corporation
Professional Background
Elena Medo is a visionary leader and an influential figure in the life sciences sector, serving as the CEO of Medolac Laboratories, a pioneering Public Benefit Corporation. Under her guidance, Medolac is on a mission to enhance the health outcomes of preterm infants globally through access to lifesaving human milk. Medolac is distinguished for being the first to offer ready-to-feed, sterile, shelf-stable human milk that can be easily shipped and stored at room temperature. This innovation not only meets a critical need but also represents a transformative shift in how nourishment is provided to the world's most vulnerable infants.
Medo's career is marked by significant accomplishments in building and funding cutting-edge life science ventures. She has successfully raised over $35 million for her last three startups, reflecting her adeptness in harnessing disruptive innovation to tackle pressing healthcare challenges. Each of her initiatives has aimed to address the issue of feeding the approximately 15 million preterm infants born annually, underscoring her commitment to improving global infant health.
Over the years, Medo has amassed a robust portfolio of innovative products and services that have set new standards in neonatal care. Her impressive track record includes the invention of a patented Soft-cup funnel breast pump in 1986 and the introduction of the first double breast pumping system. These innovations have significantly improved the experience and outcomes for breastfeeding mothers, particularly those in maternity wards.
Additionally, she was the creative force behind the first online milk bank, enhancing access to vital human milk for infants in need. Medo's drive for innovation led to the development of tailored formulations of human milk specifically designed to support the health of preterm infants. Furthermore, she was instrumental in creating the first human milk-based fortifier for preterm infants derived from actual human milk, showcasing her dedication to providing the highest quality nutrition. Medo also played a pivotal role in establishing the first milk bank owned exclusively by donors, which paved the way for a more ethical approach to milk sharing.
Education and Achievements
Elena Medo's academic background reflects a strong foundation in humanities and health sciences, which has undoubtedly shaped her approach to leadership and innovation within the healthcare sector. She earned her Bachelor of Arts in Humanities from Union Institute, providing her with a broad perspective on human experiences and societal needs. Medo furthered her education by studying Developmental and Cell Biology at the University of California, Irvine, equipping her with insights into the biological complexities that underlie infant health.
Additionally, Medo holds an MBA with a specialization in Health Care Management from The Paul Merage School of Business at the University of California, Irvine. This combination of education and experience in both the health sciences and business management has enabled her to effectively navigate the intricacies of the healthcare landscape, driving impactful changes in the industry.
Notable Achievements
Throughout her career, Elena Medo has received recognition for her substantial contributions to the field of neonatal care. Her commitment to making human milk accessible to all babies, irrespective of their economic circumstance, embodies the core mission of Medolac Laboratories. Medo's innovative work includes efforts to scale donor milk production, thereby significantly reducing the costs associated with providing donor milk to hospitals catering to fragile preterm infants.
In addition to her role at Medolac, Medo previously owned North American Instruments, a company that added to her vast experience in the technical aspects of healthcare solutions.
Elena Medo's leadership style is characterized by compassion and a clear vision for a healthier future for infants around the globe. By integrating technology and innovative methods within her work, she is not only advancing healthcare access but is also setting the stage for the next wave of breakthroughs in neonatal health. Her passionate dedication to the welfare of all infants reflects an exceptional commitment that inspires others in the field of life sciences.
Elena Medo continues to lead with purpose, ensuring that Medolac Laboratories remains at the forefront of the movement to make human milk available to all babies in need. As the world turns its attention towards the importance of nutrition and infant health, her innovative contributions will undoubtedly have a lasting impact, improving the lives of countless premature infants and their families.
